Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Primary Research
2.1.3 Key Data From Primary Sources
2.1.4 Key Insights From Primary Sources
2.1.4.1 Key Industry Insights
2.1.5 Market Size Estimation Methodology
2.1.6 Research Design
2.1.7 Market Data Validation and Triangulation
2.1.8 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Market Overview of Neuromodulation
4.2 Global Neuromodulation Market, By Type
4.3 Geographic Analysis of the Deep Brain Stimulation Market, By Application
4.4 Internal Neuromodulation Market, By Modality
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Segmentation of Neuromodulation
5.3 Market Dynamics of Neuromodulation
5.1 Drivers
5.1.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
5.1.1.2 Unprecedented Increase in the Aging Population to Fuel Market Growth
5.1.1.3 Strong Product Pipeline to Propel the Market
5.1.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
5.1.1.5 Investments and Funds – an Impetus for Market Growth
5.2 Restraints
5.2.1.1 Unfavorable Reimbursement Scenario Hinders Market Growth
5.2.1.2 Lack of Trained Professionals Likely to Hamper Market Growth
5.3 Opportunities
5.3.1.1 Expansion in Emerging Economies

6 Global Neuromodulation Market, By Technology
6.1 Introduction
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Deep Brain Stimulation (DBS)
6.2.3 Vagus Nerve Stimulation (VNS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Gastric Electrical Stimulation (GES)
6.3 External Neuromodulation (Non-Invasive)
6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
6.3.2 Transcranial Magnetic Stimulation (TMS)
6.3.3 Respiratory Electrical Stimulation (RES)

7 Global Neuromodulation Market, By Application
7.1 Introduction
7.2 Spinal Cord Stimulation (SCS) Market, By Application
7.2.1 Failed Back Syndrome (FBSS)
7.2.2 Chronic Pain
7.2.3 Ischemia
7.3 Deep Brain Stimulation (DBS) Market, By Application
7.3.1 Parkinson’s Disease
7.3.2 Tremor
7.3.3 Depression
7.3.4 Other Dbs Applications
7.4 Sacral Nerve Stimulation Market, By Application
7.4.1 Urine Incontinence
7.4.2 Fecal Incontinence
7.5 Vagus Nerve Stimulation Market, By Application
7.5.1 Epilepsy
7.5.2 Other Vns Applications
7.6 Gastric Electrical Stimulation Market, By Application
7.6.1 Gastroparesis
7.6.2 Obesity
7.7 Transcutaneous Electrical Nerve Stimulation Market, By Application
7.7.1 Treatment Resistant Depression
7.7.2 Other Tens Applications
7.8 Repetitive Transcranial Magnetic Stimulation Market, By Application
7.8.1 Depression
7.8.2 Migraine Headache
7.9 Respiratory Electrical Stimulation Market, By Application
7.9.1 Spinal Cord Injury

8 Neuromodulation Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Chronic Diseases In The U.S.
8.2.1.2 Increasing Aging Population In The U.S.
8.2.1.3 Increasing Lyme Disease Cases In The U.S.
8.2.1.4 Conferences & Annual Meetings To Increase Exposure of Neuromodulation
8.2.2 Canada
8.2.2.1 Increasing Incidence of Lyme Disease In Canada
8.2.2.2 Increasing Incidences of Cancer And Diabetes
8.2.3 Europe
8.2.3.1.1 Rapidly Aging Population In Europe
8.2.3.1.2 Conferences & Annual Meetings To Increase Exposure To Neuromodulation in the European Market
8.2.3.2 Germany
8.2.3.2.1 Rising Prevalence of Parkinson’s Disease In Germany
8.2.3.3 U.K.
8.2.3.3.1 Rising Prevalence of Diabetes In The U.K.
8.2.3.3.2 Rise In CVD Prevalence In The U.K.
8.2.3.4 France
8.2.3.4.1 Rising Incidences of Alzheimer's Disease And Dementia
8.2.3.5 Rest of Europe
8.2.3.5.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine
8.2.4 Asia-Pacific
8.2.4.1 Japan
8.2.4.1.1 Rising Adoption of Neurostimulation
8.2.4.2 China
8.2.4.2.1 High Diabetes Incidences And Rapidly Aging Population
8.2.4.3 India
8.2.4.3.1 Increasing Geriatric Population & High Diabetes Incidence
8.2.4.3.2 Conferences On Neuromodulation & Pain Management In India
8.2.4.4 Rest of Asia-Pacific (ROAPAC)
8.2.4.4.1 Increasing Prevalence of Parkinson’s Disease In Singapore
8.2.4.4.2 Conferences On Neuromodulation In Australia
8.2.5 Rest of The World
8.2.5.1.1 Increasing Incidences of Cancer In Latin America
8.2.5.1.2 Rise In Aging Population & Prevalence of Diabetes

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis fo Neuromodulation, By Key Player
9.2.1 Introduction
9.3 Medtronic, Inc.
9.4 Boston Scientific Corporation
9.5 ST. Jude Medical, Inc.
9.6 Competitive Scenario
9.6.1 Market Development of Neuromodulation
9.6.2 Agreements, Collaborations, Mergers, and Partnerships
9.6.3 New Product Launches
9.6.4 Acquisitions
9.6.5 Expansion

10 Company Profiles
10.1 Introduction
10.2 Medtronic, Inc.
10.2.1 Business Overview
10.2.2 Medtronic, Inc.: Company Snapshot
10.2.3 Products & Services
10.2.4 Recent Developments
10.2.5 MnM View
10.3 Boston Scientific Corporation
10.3.1 Business Overview
10.3.2 Boston Scientific Corporation: Company Snapshot
10.3.3 Product Offerings
10.3.4 Recent Developments
10.3.5 MnM View
10.4 ST. Jude Medical, Inc.
10.4.1 Business Overview
10.4.2 ST Jude Medical, Inc.: Company Snapshot
10.4.3 Product Offerings:
10.4.4 Recent Developments
10.4.5 MnM View
10.5 Cyberonics, Inc.
10.5.1 Business Overview
10.5.2 Cyberonics, Inc.: Company Snapshot
10.5.3 Product Portfolio
10.5.4 Recent Developments
10.6 Nevro Corporation
10.6.1 Business Overview
10.6.2 Nevro Corporation: Company Snapshot
10.6.3 Product Offerings
10.6.4 Recent Developments
10.7 Neurosigma, Inc.
10.7.1 Business Overview
10.7.2 Neurosigma, Inc.: Company Snapshot
10.7.3 Product Offerings
10.7.4 Recent Developments
10.8 Neuropace, Inc.
10.8.1 Business Overview
10.8.2 Neuropace, Inc.: Company Snapshot
10.8.3 Product Offerings
10.8.4 Recent Developments
10.9 Biocontrol Medical
10.9.1 Business Overview
10.9.2 Biocontrol Medical: Company Snapshot
10.9.3 Product Offerings
10.9.4 Recent Developments
10.10 Synapse Biomedical, Inc.
10.10.1 Business Overview
10.10.2 Synapse Biomedical, Inc.: Company Snapshot
10.10.3 Product Offerings
10.10.4 Recent Developments
10.11 Neuronetics, Inc.
10.12 Business Overview
10.12.1 Neuronetics, Inc.: Company Snapshot
10.12.2 Product and Service Offerings
10.12.3 Recent Developments

11 Appendix
11.1 Discussion Guide
11.2 Company Developments (2012-2015)
11.2.1 Medtronic, Inc.
11.2.2 Boston Scientific Corporation
11.2.3 ST Jude Medical, Inc.
11.2.4 Neurosigma, Inc.
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Reports

List of Tables

Table 1 Increasing Incidence of Neurological Disorders is Propelling the Growth of the Global Neuromodulation Market
Table 2 Unfavourable Reimbursement Structure is Restraining the Growth of the Global Neuromodulation Market
Table 3 Expansion in Emerging Markets has a Huge Potential for Growth in the Global Neuromodulation Market
Table 4 Global Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 5 Internal Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 6 Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 7 Internal Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 8 Spinal Cord Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 9 Spinal Cord Stimulation Market Size, 2013-2020 (Units)
Table 10 Deep Brain Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 11 Deep Brain Stimulation Market Size, 2013-2020 (Units)
Table 12 Vagus Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 13 Vagus Nerve Stimulation Market Size, 2013-2020 (Units)
Table 14 Sacral Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 15 Sacral Nerve Stimulation Market Size, 2013-2020 (Units)
Table 16 Gastric Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 17 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 18 External Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 19 External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 20 External Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 21 Transcutaneous Electrical Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 22 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 23 Transcranial Magnetic Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 24 Transcranial Magnetic Stimulation Market Size, 2013-2020 (Units)
Table 25 Respiratory Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 26 Respiratory Electrical Stimulation Market Size, 2013-2020 (Units)
Table 27 Global Spinal Cord Stimulation Market, By Application, 2013–2020 ($Million)
Table 28 Global Deep Brain Stimulation Market, By Application, 2013–2020 ($Million)
Table 29 Global Sacral Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 30 Global Vagus Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 31 Global Gastric Electrical Stimulation Market, By Application, 2013–2020 ($Million)
Table 32 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 33 Global Transcranial Magnetic Stimulation Market, By Application, 2013–2020 ($Million)
Table 34 Neuromodulation Market Size, By Region, 2013-2020($Million)
Table 35 North America: Neuromodulation Market Size, By Country, 2013–2020 ($Million)
Table 36 North America: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 37 North America: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 38 North America: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 39 U.S.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 40 U.S.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 41 U.S.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 42 Canada: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 43 Canada: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 44 Canada: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 45 Europe: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 46 Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 47 Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 48 Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 49 Germany: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 50 Germany: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 51 Germany: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 52 U.K.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 53 U.K.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 54 U.K.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 55 France: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 56 France: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 57 France: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 58 Rest of Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 59 Rest of Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 60 Rest of Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 61 Asia-Pacific: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 62 Asia-Pacific: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 63 Asia-Pacific: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 64 Asia-Pacific: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 65 Japan: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 66 Japan: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 67 Japan: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 68 China: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 69 China: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 70 China: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 71 India: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 72 India: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 73 India: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 74 ROAPAC: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 75 ROAPAC: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 76 ROAPAC: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 77 Rest of the World: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 78 Rest of the World: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 79 Rest of the World: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 80 Recent Developments, 2012–2014
Table 81 Recent Developments, 2012–2014
Table 82 Recent Developments, 2012–2014
Table 83 Recent Developments, 2012–2014
Table 84 Recent Developments, 2012–2014

List of Figures

Figure 1 Market Segmentation
Figure 2 Market Research Methodology Steps
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Internal Neuromodulation Segment to Witness the Highest CAGR of11.4% From 2015 to 2020
Figure 8 Deep Brain Stimulation to Grow at the Highest CAGR of 14.2% During the Forecast Period
Figure 9 Transcutaneous Electrical Nerve Stimulation is Expected to Command the Largest Share in 2015
Figure 10 Parkinson’s Disease is Expected to Command the Largest Share in 2015
Figure 11 Asia-Pacific Slated to Witness the Highest Growth in the Neuromodulation Market During the Forecast Period
Figure 12 Attractive Opportunities in the Neuromodulation Market
Figure 13 Internal Modulation Technology to Witness the Highest Growth During the Forecast Period
Figure 14 North America to Dominate the Neuromodulation Market
Figure 15 Deep Brain Stimulation Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 Asia-Pacific to Witness Highest Growth Rate From 2015 to 2020
Figure 17 Global Neuromodulation Market, By Type
Figure 18 Internal Neuromodulation Segment to Grow at the Highest CAGR of11.2% During the Forecast Period
Figure 19 Asia-Pacific to Grow at the Highest CAGR of 14.9% During the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest CAGR of 13.4% During the Forecast Period
Figure 21 Transcranial Magnetic Stimulation to Grow at the Highest CAGR During the Forecast Period
Figure 22 Global  Internal Neuromodulation  Market, By Application
Figure 23 Global  External Neuromodulation  Market, By Application
Figure 24 North America is Expected to Command the Largest Share of the Global Market in 2015
Figure 25 U.S. to Witness the Highest Growth in the Global Market in North America (2015)
Figure 26 Germany to Witness the Highest Growth in the Global Neuromodulation Market in Europe (2015)
Figure 27 Asia-Pacific, the Fastest-Growing Segment in the Global Market
Figure 28 RoW Expected to Grow at A CAGR of 13.3% During 2015 to 2020
Figure 29 Market Share Analysis of Neuromodulation, By Key Player, 2014
Figure 30 Neuromodulation Strategies Adopted By Key Players Over the Last Four Years (2012-2015)
Figure 31 Battle for Market Share of Neuromodulation: Market Develpoment was the Key Strategy
Figure 32 Neuromodulation Geographical Revenue Mix of Top Players

• Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
  As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
• World Economic Forum Unveils Top 10 Emerging Technologies of 2016
  The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
• Siemens Adds To the Growth of Wind Power Generation Market
  Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
• Global Public Safety LTE Ecosystem Overview
  In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
• RnR Market Research: Biochips Market Insights
  Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
• In The Next Five Years Robot Doctors To Execute One In Three Surgeries In The US

Experts say that surgical robots or robot doctors will be conducting one in three operations in the US in the next five years. The surgical robots are estimated to multiply two folds by 2021, with surgeons guiding mechanical them on comp…

• Global Elevator Market Gets a Boost Owing To Green Elevators' Demand

Green building constituents are usually those that lessen the ecological footprint by concentrating on the usage of renewable resources. With numerous building products being marketed as eco-friendly, elevators and escalators have also b…

• Burgeoning Growth Of Internet To Boost The Global Cloud Storage Market

The gradually growing habit and demand of internet is predicted to escalate the global cloud storage market. The call for storage has been swelling in organizations with the amassing and digitization of records and the incompetence of ou…

• Future Trends In The Shipping Industry

The shipping industry is continuously progressing and struggling for improved modernization. The past few years have been exceptionally interesting. Foremost trends like containerisation and globalisation have redesigned the commerce and…

• Green Tea And Black Tea Demand Continues To Boost Global Tea Market

After water, tea is the most popular beverage globally. Maximum of tea consumption is locally, in the country or region of production. The tea sector is marked by a handful of companies monitoring the complete tea supply chain. 85% of to…

Global Transilluminators Market Research Report 2016

Published: 24-Aug-2016        Price: US 2900 Onwards        Pages: 114

Notes: Production, means the output of Transilluminators Revenue, means the sales value of Transilluminators This report studies Transilluminators in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AUXILAB S.L - InSono S.r.l - UVP, LLC - Nanolytik - Syngene......

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 49

Global Markets Direct's, ‘Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016', provides in depth analysis on Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) targeted pipeline therapeutics. The report provides comprehensive information on the Potassi......

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 51

Global Markets Direct's, ‘Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016', provides in depth analysis on Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) targeted pipeline therapeutics. The report provides comprehensive information on the Proba......

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 90

Global Markets Direct's, ‘Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016', provides in depth analysis on Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted pipeline therapeutics. The report provides comprehensive information on the Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) a......

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 44

Global Markets Direct's, ‘Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016', provides in depth analysis on Cell Division Protein FtsZ (ftsz) targeted pipeline therapeutics. The report provides comprehensive information on the Cell Division Protein FtsZ (ftsz), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologic......

Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 46

Global Markets Direct's, ‘Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016', provides in depth analysis on Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) targeted pipeline therapeutics. The report provides comprehensive information on the Leukocyte Surface Antigen CD47 (Antigenic Surface Deter......

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 40

Global Markets Direct's, ‘Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H2 2016', provides in depth analysis on Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted pipeline therapeutics. The report provides comprehensive information on the Midkine (Amphiregulin Associated Protein or Midgestation And Kidney......

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 45

Global Markets Direct's, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016', provides in depth analysis on Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted pipeline therapeutics. The report provides comprehensive information on the Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism o......

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016

Published: 24-Aug-2016        Price: US 3500 Onwards        Pages: 38

Global Markets Direct's, ‘Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016', provides in depth analysis on Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) targeted pipeline therapeutics. The report provides comprehensive information on the Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) , targeted therapeutics, co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs